TY - JOUR
T1 - Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases
AU - Igarashi, Hisato
AU - Ito, Tetsuhide
AU - Oono, Takamasa
AU - Nakamura, Taichi
AU - Fujimori, Nao
AU - Niina, Yusuke
AU - Hijioka, Masayuki
AU - Uchida, Masahiko
AU - Lee, Ringaku
AU - Iwao, Risa
AU - Nakamura, Kazuhiko
AU - Kotoh, Kazuhiro
AU - Takayanagi, Ryoichi
PY - 2012/5
Y1 - 2012/5
N2 - Objective: We aimed to investigate the relationship between the number of involved organs or regions and serum immunoglobulin G (IgG) and immunoglobulin G4 (IgG4) levels. Methods: The number of pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels were examined by groups in 46 patients with IgG4-related diseases at diagnosis prior to the initiation of steroid treatment: group A (one region involved, n=7), group B (two regions involved, n=11), group C (three regions involved, n=12), group D (four regions involved, n=9) and group E (five to seven regions involved, n=7). Results: Both serum IgG and IgG4 levels increased with the number of inflamed regions. Mean serum IgG levels were 15.11, 18.65, 20.92, 23.29 and 30.98g/L while the mean IgG4 levels were 3.99, 4.70, 4.70, 9.86 and 16.49g/L in group A, B, C, D and E, respectively. Regression analysis also suggested that IgG4 was positively correlated with the number of regions involved. Additionally, serum IgG4 was higher in patients with multiple lesions when accompanied by sclerosing sialadenitis. Conclusion: Patients having IgG4-related disease with high serum IgG and IgG4 levels should be systematically examined for involved lesions.
AB - Objective: We aimed to investigate the relationship between the number of involved organs or regions and serum immunoglobulin G (IgG) and immunoglobulin G4 (IgG4) levels. Methods: The number of pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels were examined by groups in 46 patients with IgG4-related diseases at diagnosis prior to the initiation of steroid treatment: group A (one region involved, n=7), group B (two regions involved, n=11), group C (three regions involved, n=12), group D (four regions involved, n=9) and group E (five to seven regions involved, n=7). Results: Both serum IgG and IgG4 levels increased with the number of inflamed regions. Mean serum IgG levels were 15.11, 18.65, 20.92, 23.29 and 30.98g/L while the mean IgG4 levels were 3.99, 4.70, 4.70, 9.86 and 16.49g/L in group A, B, C, D and E, respectively. Regression analysis also suggested that IgG4 was positively correlated with the number of regions involved. Additionally, serum IgG4 was higher in patients with multiple lesions when accompanied by sclerosing sialadenitis. Conclusion: Patients having IgG4-related disease with high serum IgG and IgG4 levels should be systematically examined for involved lesions.
UR - http://www.scopus.com/inward/record.url?scp=84859829513&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859829513&partnerID=8YFLogxK
U2 - 10.1111/j.1751-2980.2012.00583.x
DO - 10.1111/j.1751-2980.2012.00583.x
M3 - Article
C2 - 22500790
AN - SCOPUS:84859829513
SN - 1751-2972
VL - 13
SP - 274
EP - 279
JO - Journal of Digestive Diseases
JF - Journal of Digestive Diseases
IS - 5
ER -